BLOOD BILIRUBIN ABNORMAL side effect
What is BLOOD BILIRUBIN ABNORMAL ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
BLOOD BILIRUBIN ABNORMAL and Recently Reported Side Effects
BLOOD BILIRUBIN ABNORMAL and 15 most Active Side Effect polls
BLOOD BILIRUBIN ABNORMAL and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with BLOOD BILIRUBIN ABNORMAL
ACCUTANE ALIMTA AMOXICILLIN ARGATROBAN BEVACIZUMAB CARBOPLATIN CHANTIX CLOZARIL ETOPOSIDE INTRALIPID KYTRIL LAPATINIB METHADONE MIRTAZAPINE PEDIMUNE RIFAMPICIN SIMVASTATIN TOFRANIL TRACLEER WINRHO ZOCORPedimune Side Effects Report #5679525-7
Consumer or non-health professional from reported PEDIMUNE problem on Mar 12, 2008. Female patient was diagnosed with hiv infection and was treated with PEDIMUNE. After drug was administered, patient experienced the following problems/side effects: blood bilirubin abnormal, pneumonia, . PEDIMUNE dosage: unknown. Patient died.
Clozaril Side Effects Report #5731652-1
CLOZARIL problem was reported by a Health Professional from AUSTRALIA on Apr 30, 2008. Male patient, 49 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: blood bilirubin abnormal, platelet count decreased, splenomegaly, troponin increased, . CLOZARIL dosage: 100MG. Patient was hospitalized. Patient recovered.
Amoxicillin Side Effects Report #5705719-8
Consumer or non-health professional from BRAZIL reported AMOXICILLIN problem on Apr 09, 2008. Female patient, 32 years of age, weighting 154.3 lb, was diagnosed with sinusitis and was treated with AMOXICILLIN. After drug was administered, patient experienced the following problems/side effects: blood bilirubin abnormal, encephalopathy, hepatitis, nausea, prothrombin level abnormal, transaminases abnormal, . AMOXICILLIN dosage: unknown. Patient was hospitalized. Patient died on 04/03/2008.
Carboplatin Side Effects Report #5328300-1
CARBOPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 15, 2007. Female patient, weighting 158.4 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: blood bilirubin abnormal, blood bilirubin increased, dizziness, haemoglobin abnormal, hypoglycaemia, nausea, platelet count abnormal, pyrexia, vomiting, . CARBOPLATIN dosage: 455 MG. During the same period patient was treated with GLYBURIDE, LIPITOR, LISINOPRIL, ASPIRIN. Patient was hospitalized. Patient recovered.
Zocor Side Effects Report #5293355-X
Health Professional from UNITED KINGDOM reported ZOCOR problem on Apr 02, 2007. Male patient, 68 years of age, was diagnosed with blood cholesterol increased and was treated with ZOCOR. After drug was administered, patient experienced the following problems/side effects: blood bilirubin abnormal, platelet count decreased, . ZOCOR dosage: unknown. Patient recovered.
Simvastatin Side Effects Report #5300430-X
SIMVASTATIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 02, 2007. Male patient was treated with SIMVASTATIN. After drug was administered, patient experienced the following problems/side effects: blood bilirubin abnormal, blood glucose increased, platelet count decreased, . SIMVASTATIN dosage: unknown. Patient recovered.
Simvastatin Side Effects Report #5302351-5
Health Professional from UNITED KINGDOM reported SIMVASTATIN problem on Apr 02, 2007. Male patient was treated with SIMVASTATIN. After drug was administered, patient experienced the following problems/side effects: blood bilirubin abnormal, blood glucose increased, platelet count decreased, . SIMVASTATIN dosage: unknown. Patient recovered.
Accutane Side Effects Report #5329591-3
ACCUTANE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 10, 2006. Female patient, weighting 6.39 lb, was diagnosed with acne and was treated with ACCUTANE. After drug was administered, patient experienced the following problems/side effects: blood bilirubin abnormal, normal newborn, premature baby, premature labour, . ACCUTANE dosage: unknown. Patient recovered.
Accutane Side Effects Report #5329625-6
Consumer or non-health professional from UNITED STATES reported ACCUTANE problem on Mar 10, 2006. Female patient, weighting 6.39 lb, was diagnosed with acne and was treated with ACCUTANE. After drug was administered, patient experienced the following problems/side effects: blood bilirubin abnormal, normal newborn, premature baby, premature labour, . ACCUTANE dosage: unknown. Patient recovered.
Alimta Side Effects Report #5631961-0
ALIMTA problem was reported by a Physician from UNITED STATES on Feb 11, 2008. Male patient, weighting 273.0 lb, was diagnosed with adenocarcinoma pancreas, constipation and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: blood albumin abnormal, blood bilirubin abnormal, blood glucose abnormal, pulmonary artery thrombosis, supraventricular tachycardia, . ALIMTA dosage: 300 MG/M2, OTHER. During the same period patient was treated with LEVAQUIN, COUMADIN, MIRALAX, LOVENOX, LOPRESSOR, SENOKOT. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5640848-9
Physician from UNITED STATES reported ALIMTA problem on Feb 19, 2008. Male patient, weighting 273.0 lb, was diagnosed with adenocarcinoma pancreas, constipation and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: blood albumin abnormal, blood bilirubin abnormal, blood glucose abnormal, pulmonary artery thrombosis, supraventricular tachycardia, . ALIMTA dosage: 300 MG/M2, OTHER. During the same period patient was treated with LEVAQUIN, COUMADIN, MIRALAX, LOVENOX, LOPRESSOR, SENOKOT. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5521176-9
ALIMTA problem was reported by a Physician from UNITED STATES on Nov 09, 2007. Male patient was diagnosed with adenocarcinoma pancreas and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: blood albumin abnormal, blood bilirubin abnormal, blood glucose abnormal, chest x-ray abnormal, supraventricular tachycardia, . ALIMTA dosage: 300 MG/M2, OTHER. During the same period patient was treated with LEVAQUIN, COUMADIN, MIRALAX, LOVENOX, LOPRESSOR, SENOKOT, ASPIRIN. Patient was hospitalized. Patient recovered.
Winrho Side Effects Report #5531284-4
Consumer or non-health professional from CANADA reported WINRHO SDF problem on Nov 12, 2007. Male patient, 74 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with WINRHO SDF. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood bilirubin abnormal, blood disorder, blood lactate dehydrogenase abnormal, chills, haemolysis, hypertension, immune system disorder, oxygen saturation decreased, . WINRHO SDF dosage: unknown. During the same period patient was treated with WINRHO SDF, WINRHO SDF. Patient recovered.
Chantix Side Effects Report #5446632-3
CHANTIX problem was reported by a Physician from UNITED STATES on Aug 28, 2007. Male patient, weighting 203.9 lb, was diagnosed with nicotine dependence, diabetes mellitus and was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: asthenia, blood bilirubin abnormal, blood creatinine increased, blood glucose increased, blood urea increased, diarrhoea, dizziness, headache, hyperhidrosis, . CHANTIX dosage: unknown. During the same period patient was treated with INSULIN. Patient recovered.
Etoposide Side Effects Report #5381456-7
Consumer or non-health professional from NETHERLANDS reported ETOPOSIDE problem on July 03, 2007. Male patient, 59 years of age, weighting 145.5 lb, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: atelectasis, blood bilirubin abnormal, bronchospasm, dyspnoea, hepatic function abnormal, hypokalaemia, hyponatraemia, lung infiltration, . ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient recovered.
Mirtazapine Side Effects Report #5395625-3
MIRTAZAPINE problem was reported by a Health Professional from CANADA on July 16, 2007. Male patient, 45 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: areflexia, blood bilirubin abnormal, blood creatine phosphokinase increased, intentional overdose, platelet count decreased, suicide attempt, therapeutic agent toxicity, unresponsive to stimuli, vestibular disorder, . MIRTAZAPINE dosage: 225 MG ONCE ORAL. During the same period patient was treated with BACLOFEN, VECURONIUM BROMIDE, SUCCINYLCHOLINE CHLORIDE, PROPOFOL, MIDAZOLAM. Patient was hospitalized. Patient recovered.
Etoposide Side Effects Report #5381456-7
Consumer or non-health professional from NETHERLANDS reported ETOPOSIDE problem on July 03, 2007. Male patient, 59 years of age, weighting 145.5 lb, was diagnosed with acute myeloid leukaemia and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: atelectasis, blood bilirubin abnormal, bronchospasm, dyspnoea, hepatic function abnormal, hypokalaemia, hyponatraemia, lung infiltration, . ETOPOSIDE dosage: unknown. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient recovered.
Mirtazapine Side Effects Report #5395625-3
MIRTAZAPINE problem was reported by a Health Professional from CANADA on July 16, 2007. Male patient, 45 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: areflexia, blood bilirubin abnormal, blood creatine phosphokinase increased, intentional overdose, platelet count decreased, suicide attempt, therapeutic agent toxicity, unresponsive to stimuli, vestibular disorder, . MIRTAZAPINE dosage: 225 MG ONCE ORAL. During the same period patient was treated with BACLOFEN, VECURONIUM BROMIDE, SUCCINYLCHOLINE CHLORIDE, PROPOFOL, MIDAZOLAM. Patient was hospitalized. Patient recovered.
Methadone Side Effects Report #5725585-4
Consumer or non-health professional from reported METHADONE problem on Apr 25, 2008. Male patient, 34 years of age, was diagnosed with sinus bradycardia and was treated with METHADONE. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, blood bilirubin abnormal, bradycardia, crepitations, fall, hyperhidrosis, hypotension, loss of consciousness, sinus bradycardia, . METHADONE dosage: unknown. During the same period patient was treated with FLURAZEPAM, ATAZANAVIR SULPHATE, RITONAVIR, TRUVADA, AMOXICILLIN, INTRAVENOUS FLUIDS, OXYGEN, ATROPINE. Patient was hospitalized. Patient recovered.
Lapatinib Side Effects Report #5726414-5
LAPATINIB problem was reported by a Physician from UNITED KINGDOM on Apr 23, 2008. Male patient, 53 years of age, weighting 210.3 lb, was diagnosed with hypertension and was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase abnormal, blood bilirubin abnormal, . LAPATINIB dosage: 1500MG PER DAY. During the same period patient was treated with CISPLATIN, CANDESARTAN CILEXETIL. Patient recovered.
Tofranil Side Effects Report #5257133-X
Consumer or non-health professional from BRAZIL reported TOFRANIL problem on Feb 22, 2007. Female patient, 60 years of age, was diagnosed with depression and was treated with TOFRANIL. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, blood bilirubin abnormal, liver disorder, . TOFRANIL dosage: 25 MG/D. Patient recovered.
Argatroban Side Effects Report #5671888-1
ARGATROBAN problem was reported by a Consumer or non-health professional from JAPAN on Feb 27, 2008. Male patient, 60 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with ARGATROBAN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood alkaline phosphatase abnormal, blood bilirubin abnormal, blood lactate dehydrogenase abnormal, gamma-glutamyltransferase abnormal, hepatic function abnormal, . ARGATROBAN dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, ANTIBIOTICS. Patient was hospitalized and became disabled. Patient recovered.
Intralipid Side Effects Report #5603415-9
Consumer or non-health professional from reported INTRALIPID problem on Dec 07, 2007. Male patient, weighting 2.43 lb, was diagnosed with parenteral nutrition and was treated with INTRALIPID. After drug was administered, patient experienced the following problems/side effects: abdominal distension, bilirubin conjugated abnormal, blood bilirubin abnormal, failure to thrive, hepatic enzyme increased, incorrect dose administered, intraventricular haemorrhage, neonatal disorder, . INTRALIPID dosage: unknown. During the same period patient was treated with PARENTERAL NUTRITION. Patient recovered.
Tracleer Side Effects Report #5578545-0
TRACLEER problem was reported by a Consumer or non-health professional from GERMANY on Dec 12, 2007. Female patient, 26 years of age, weighting 114.6 lb, was diagnosed with pulmonary hypertension and was treated with TRACLEER. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin abnormal, infection, pyrexia, . TRACLEER dosage: 125 MG, BID, ORAL. During the same period patient was treated with ENOXAPARIN, ACETYLDIGOXIN, ACETYLSALICYLIC ACID SRT, ZYPREXA, TOREM, PANTOZOL, SPIRONOLACTONE, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5483065-8
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on Sept 26, 2007. Female patient, weighting 101.4 lb, was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase abnormal, aspartate aminotransferase abnormal, blood bilirubin abnormal, neutrophil count decreased, onycholysis, platelet count decreased, pyrexia, white blood cell count decreased, . BEVACIZUMAB dosage: 5 MG/KG, QD. During the same period patient was treated with ISOVORIN, OXALIPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5483068-3
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Sept 27, 2007. Male patient was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase abnormal, aspartate aminotransferase abnormal, blood bilirubin abnormal, platelet count abnormal, pneumonia aspiration, white blood cell count abnormal, . BEVACIZUMAB dosage: unknown. During the same period patient was treated with OXALIPLATIN, ISOVORIN, FLUOROURACIL. Patient died on 09/26/2007.
Bevacizumab Side Effects Report #5483076-2
Physician from UNITED KINGDOM reported BEVACIZUMAB problem on Sept 26, 2007. Male patient was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase abnormal, aspartate aminotransferase abnormal, blood bilirubin abnormal, hyperbilirubinaemia, metastasis, neuropathy peripheral, palmar-plantar erythrodysaesthesia syndrome, platelet count abnormal, platelet count decreased, . BEVACIZUMAB dosage: 10 MG/KG, UNK. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, LOXONIN, URSO, MUCOSTA, FAMOTIDINE. Patient recovered.
Kytril Side Effects Report #5745033-8
KYTRIL problem was reported by a Physician from JAPAN on May 15, 2008. Male patient was diagnosed with rectal cancer metastatic and was treated with KYTRIL. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase abnormal, aspartate aminotransferase abnormal, blood bilirubin abnormal, haematuria, platelet count abnormal, protein urine, retinal detachment, retinal haemorrhage, white blood cell count abnormal, . KYTRIL dosage: unknown. During the same period patient was treated with AVASTIN, FLUOROURACIL, RESTAMIN, VOLTAREN, ISOVORIN, ELPLAT. Patient was hospitalized. Patient recovered.
Rifampicin Side Effects Report #5338799-2
Physician from BRAZIL reported RIFAMPICIN problem on May 18, 2007. Female patient, 37 years of age, weighting 138.9 lb, was diagnosed with leprosy and was treated with RIFAMPICIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, blood alkaline phosphatase decreased, blood bilirubin abnormal, blood glucose decreased, blood sodium decreased, cyanosis, discomfort, fatigue, . RIFAMPICIN dosage: unknown. During the same period patient was treated with DAPSONE, CLOFAZIMINE. Patient recovered.